Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hedner

Showing results (221-230 of 242) with videos related to

Pageof 25
Sort By:
Journal of the American College of Cardiology|March 1, 1995
Recombinant lys-plasminogen, but not glu-plasminogen, improves recombinant tissue-type plasminogen activator-induced coronary thrombolysis in dogsJ L Mehta, L Chen, W W Nichols, et al.
Biochemistry|October 29, 1991
The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activityO Nordfang, S E Bjørn, S Valentin, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2012
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIaC A Clark, R Vatsyayan, U Hedner, et al.
Biochemistry|October 4, 1988
Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cellsL Thim, S Bjoern, M Christensen, et al.
Thrombosis Research|February 15, 1996
Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitorJ Holst, B Lindblad, G Westerlund, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulationM Kjalke, D M Monroe, M Hoffman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 12, 2007
Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogramM Lak, B Scharling, A Blemings, et al.
FEBS Letters|February 15, 1993
FVIIa derivatives obtained by autolytic and controlled cathepsin G mediated cleavageE M Nicolaisen, L Thim, J K Jacobsen, et al.
Thrombosis and Haemostasis|November 19, 1997
The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administrationM Kjalke, J A Oliver, D M Monroe, et al.
Haemostasis|March 1, 1993
Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis modelJ Holst, B Lindblad, D Bergqvist, et al.
Pageof 25

Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|March 1, 1995
Recombinant lys-plasminogen, but not glu-plasminogen, improves recombinant tissue-type plasminogen activator-induced coronary thrombolysis in dogsJ L Mehta, L Chen, W W Nichols, et al.
Biochemistry|October 29, 1991
The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activityO Nordfang, S E Bjørn, S Valentin, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2012
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIaC A Clark, R Vatsyayan, U Hedner, et al.
Biochemistry|October 4, 1988
Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cellsL Thim, S Bjoern, M Christensen, et al.
Thrombosis Research|February 15, 1996
Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitorJ Holst, B Lindblad, G Westerlund, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulationM Kjalke, D M Monroe, M Hoffman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 12, 2007
Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogramM Lak, B Scharling, A Blemings, et al.
FEBS Letters|February 15, 1993
FVIIa derivatives obtained by autolytic and controlled cathepsin G mediated cleavageE M Nicolaisen, L Thim, J K Jacobsen, et al.
Thrombosis and Haemostasis|November 19, 1997
The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administrationM Kjalke, J A Oliver, D M Monroe, et al.
Haemostasis|March 1, 1993
Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis modelJ Holst, B Lindblad, D Bergqvist, et al.
Pageof 25